Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis

scientific article published on 22 June 2012

Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S1470-2045(12)70242-5
P698PubMed publication ID22727222
P5875ResearchGate publication ID228061304

P50authorSuresh SenanQ37830477
Berend J SlotmanQ40690934
P2093author name stringCornelis J A Haasbeek
Frank J Lagerwaard
Sashendra Senthi
P2860cites workIncidence of local recurrence and second primary tumors in resected stage I lung cancerQ72395348
Post-recurrence survival in completely resected stage I non-small cell lung cancer with local recurrenceQ83406598
Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapyQ83768631
Survey of stereotactic body radiation therapy in Japan by the Japan 3-D Conformal External Beam Radiotherapy GroupQ84524583
Global cancer statisticsQ22241238
What is the most effective follow-up model for lung cancer patients? A systematic reviewQ27692019
Stereotactic body radiation therapy for inoperable early stage lung cancerQ34010065
Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): a systematic reviewQ34312788
Clinical stage I non-small cell lung cancer including FDG-PET Imaging: sites and time to recurrenceQ36839053
Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition).Q36943220
Follow-up and surveillance of the lung cancer patient following curative intent therapy: ACCP evidence-based clinical practice guideline (2nd edition).Q36943237
Radiotherapy for lung cancer: clinical impact of recent technical advancesQ37260796
Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small cell lung cancer: a meta-analysisQ37592621
Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: clinical implicationsQ37675308
Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery?Q37773607
Curative treatment of Stage I non-small-cell lung cancer in patients with severe COPD: stereotactic radiotherapy outcomes and systematic reviewQ37884743
Radiographic changes after lung stereotactic ablative radiotherapy (SABR)--can we distinguish recurrence from fibrosis? A systematic review of the literatureQ37981413
A survey of stereotactic body radiotherapy use in the United StatesQ39771088
Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL studyQ40010886
Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial.Q43972336
Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-small-cell lung cancer: a population-based time-trend analysisQ44592987
Early-stage lung cancer in elderly patients: a population-based study of changes in treatment patterns and survival in the NetherlandsQ44961453
The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer.Q45010965
Four-dimensional CT scans for treatment planning in stereotactic radiotherapy for stage I lung cancerQ47902297
Outcomes of stereotactic ablative radiotherapy following a clinical diagnosis of stage I NSCLC: comparison with a contemporaneous cohort with pathologically proven disease.Q53090898
Traditional versus up-front [18F] fluorodeoxyglucose-positron emission tomography staging of non-small-cell lung cancer: a Dutch cooperative randomized study.Q53258025
Outcomes of Stereotactic Ablative Radiotherapy in Patients With Potentially Operable Stage I Non-Small Cell Lung CancerQ59587407
Rapid delivery of stereotactic radiotherapy for peripheral lung tumors using volumetric intensity-modulated arcsQ59587517
Outcomes of Risk-Adapted Fractionated Stereotactic Radiotherapy for Stage I Non–Small-Cell Lung CancerQ59587541
Has 3-D conformal radiotherapy (3D CRT) improved the local tumour control for stage I non-small cell lung cancer?Q59587665
P433issue8
P921main subjectadaptive radiation therapyQ180507
lung cancerQ47912
P304page(s)802-809
P577publication date2012-06-22
P1433published inLancet Oncology CommissionQ13747613
P1476titlePatterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis
P478volume13